| Study | Stroke onset to recanalization, min | Initial NIHSS score | Initial ASPECT score | MT attempts | IV tPA (%) | ||||||||||
| Total | M1 | M2 | Total | M1 | M2 | Total | M1 | M2 | Total | M1 | M2 | Total | M1 | M2 | |
| Lapergue et al 18 | 268.5 | NR | NR | 16.2 | NR NR | 7 | NR | NR | 2 | NR | NR | 56 | NR | NR | |
| Salahuddin et al 10 | 289 (203–464) | 324 (210–504) | 242 (200–367) | 16 (12–21) | 17 (12–21) | 14 (9–18) | 9 (8–9) | 9 (8–9) | 9 (8–9.25) | 2.11±1.66 | 2.20±1.76 | 1.88±1.37 | 42.4 | 37.9 | 54.2 |
| Bhogal et al 12 | 363.3±17 | 353±5.1 | 399±7.5 | 15 | 15.7 | 11.8 | 8.5±1.8 | 8.5±1.88 | 8.5±1.7 | 2.2±1.6 | 2.3±1.7 | 1.8±1.2 | NR | NR | NR |
| Coutinho et al 13 | NR | NR | NR | 16.3 | 17 (14–20) | 13 (10–17) | 8.3±1.6 | 8.2±1.7 | 9±1.3 | 1.6±0.9 | 1.7±1 | 1.4±0.8 | 70 | 69% | 77% |
| Castonguay et al 19 | NR | NR | NR | 17 | 18(14-22) | 14 (7–9) | NR | NR | NR | 1.8 (1–3) | 2 (1–3) | 1 (1–2) | NR | NR | NR |
| Protto et al 14 | 238±103 | 246±110 | 211±99 | 14.5±5q | 16±6 | 14±6 | 9±3 | 9±3 | 10±1 | NR | NR | NR | 63 | 65 | 41 |
| Dorn et al 17 | NR | NR | NR | 15.8±7.5 | 16.1±7.3 | 13.7±8.3 | NR | NR | NR | 2.3±1.7 | 2.3±1.7 | 2.1±1.7 | 50.5 | 51 | 46.7 |
| Atchaneeyasakul et al 20 | NA | NA | NA | NA | NA | ||||||||||
| Kim et al 15 | 285.5 | NA | 285.5 | 13 | NA | 13 | 7.5 (6.75–9) | NA | 7.5 (6.75–9) | NR | NA | NR | 48.8 | NA | 48.8 |
| Sarraj et al 22 | 311 | NA | 311 | 16(11–20) | NA | 16(11-20) | 9 (7–10) | NA | 9 (7–10) | NR | NA | NR | 59.7 | NA | 59.7 |
| Park and Kwak21 | NR | NA | NR | 10.9±5.1 | NA | 10.9±5.1 | NR | NA | NR | NR | NA | NR | 87 | NA | 87 |
| Flores et al 16 | NR | NA | NR | 16 | NA | 16 | NR | NA | NR | NR | NA | NR | 54 | NA | 54 |
ASPECTS, Alberta Stroke Program Early CT score; IV, intravenous; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; sICH, symptomatic intracranial hemorrhage; TICI, Thrombolysis in Cerebral Infarction; tPA, tissue plasminogen activator; NA, not applicable; NR, not reported.